These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17945070)

  • 1. Population differences in death rates in HIV-positive patients with tuberculosis.
    Ciglenecki I; Glynn JR; Mwinga A; Ngwira B; Zumla A; Fine PE; Nunn A
    Int J Tuberc Lung Dis; 2007 Oct; 11(10):1121-8. PubMed ID: 17945070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.
    Mwinga A; Nunn A; Ngwira B; Chintu C; Warndorff D; Fine P; Darbyshire J; Zumla A;
    Lancet; 2002 Oct; 360(9339):1050-5. PubMed ID: 12383985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia.
    Elliott AM; Hayes RJ; Halwiindi B; Luo N; Tembo G; Pobee JO; Nunn PP; McAdam KP
    AIDS; 1993 Jul; 7(7):981-7. PubMed ID: 8357557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi.
    Glynn JR; Warndorff DK; Fine PE; Munthali MM; Sichone W; Pönnighaus JM
    Bull World Health Organ; 1998; 76(3):295-305. PubMed ID: 9744250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What has Karonga taught us? Tuberculosis studied over three decades.
    Crampin AC; Glynn JR; Fine PE
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):153-64. PubMed ID: 19146741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn P
    Trans R Soc Trop Med Hyg; 1995; 89(1):78-82. PubMed ID: 7747316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study.
    Duncan LE; Elliott AM; Hayes RJ; Hira SK; Tembo G; Mumba GT; Ebrahim SH; Quigley M; Pobee JO; McAdam KP
    Trans R Soc Trop Med Hyg; 1995; 89(1):37-40. PubMed ID: 7747304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis.
    Richter C; Koelemay MJ; Swai AB; Perenboom R; Mwakyusa DH; Oosting J
    Tuber Lung Dis; 1995 Dec; 76(6):510-7. PubMed ID: 8593371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
    Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
    Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and tuberculosis in rural sub-Saharan Africa: a cohort study with two year follow-up.
    Kelly PM; Cumming RG; Kaldor JM
    Trans R Soc Trop Med Hyg; 1999; 93(3):287-93. PubMed ID: 10492761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of sputum smear-positive tuberculosis patients with and without HIV infection in a hospital in Zimbabwe.
    Schoch OD; Rieder HL
    Eur Respir J; 1996 Feb; 9(2):284-7. PubMed ID: 8777965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence.
    Hargreaves NJ; Kadzakumanja O; Whitty CJ; Salaniponi FM; Harries AD; Squire SB
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):847-54. PubMed ID: 11573897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.
    Mwinga A; Hosp M; Godfrey-Faussett P; Quigley M; Mwaba P; Mugala BN; Nyirenda O; Luo N; Pobee J; Elliott AM; McAdam KP; Porter JD
    AIDS; 1998 Dec; 12(18):2447-57. PubMed ID: 9875583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality.
    Nunn P; Brindle R; Carpenter L; Odhiambo J; Wasunna K; Newnham R; Githui W; Gathua S; Omwega M; McAdam K
    Am Rev Respir Dis; 1992 Oct; 146(4):849-54. PubMed ID: 1416409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mortality rates in tuberculosis patients in Zomba Hospital, Malawi, during 32 months of follow-up.
    Kang'ombe C; Harries AD; Banda H; Nyangulu DS; Whitty CJ; Salaniponi FM; Maher D; Nunn P
    Trans R Soc Trop Med Hyg; 2000; 94(3):305-9. PubMed ID: 10975007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB.
    Kang'ombe CT; Harries AD; Ito K; Clark T; Nyirenda TE; Aldis W; Nunn PP; Semba RD; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Jul; 8(7):829-36. PubMed ID: 15260273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
    Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis.
    Boeree MJ; Sauvageot D; Banda HT; Harries AD; Zijlstra EE
    Trop Med Int Health; 2005 Aug; 10(8):723-33. PubMed ID: 16045458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
    Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
    BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.